SCHEMBL4757041

SCHEMBL4757041

COc1ccc(-c2cnn3c(N)c(-c4cccc(Cl)c4)c(C)nc23)c(OC)c1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FYN P06241 2/20 0.53
MEN1 O00255 7/20 0.51
KMT2A Q03164 7/20 0.51
NPC1 O15118 7/20 0.51
CASP3 P42574 2/20 0.51
SENP8 Q96LD8 2/20 0.51
SENP7 Q9BQF6 2/20 0.51
SENP6 Q9GZR1 2/20 0.51
RAB9A P51151 7/20 0.48
RXFP1 Q9HBX9 1/20 0.46
BLM P54132 1/20 0.46
NCOA1 Q15788 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
RET P07949 6/20 0.40
KIF5B P33176 6/20 0.40
KDR P35968 5/20 0.40
ETV6 P41212 5/20 0.40
CCDC6 Q16204 4/20 0.40
ABL1 P00519 1/20 0.40
LCK P06239 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4178858 0.88 FYN (0.57) FYNMEN1KMT2ANPC1CASP3
SCHEMBL4179850 0.86 FYN (0.71) FYNMEN1KMT2ANPC1CASP3
SCHEMBL13905642 0.86 FYN (0.52) FYNMEN1KMT2ANPC1CASP3
SCHEMBL4178628 0.82 KMT2A (0.69) FYNMEN1KMT2ANPC1CASP3
SCHEMBL4168402 0.82 KMT2A (0.58) FYNMEN1KMT2ANPC1CASP3
SCHEMBL4171309 0.81 LCK (0.50) FYNMEN1KMT2ANPC1CASP3
SCHEMBL4163338 0.81 LCK (0.50) FYNMEN1KMT2ANPC1CASP3
SCHEMBL4173163 0.80 FYN (0.47) FYNMEN1KMT2ANPC1CASP3
SCHEMBL4174571 0.80 FYN (0.47) FYNMEN1KMT2ANPC1CASP3
SCHEMBL4180644 0.80 NPC1 (0.47) FYNMEN1KMT2ANPC1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1993552-A2 USE OF PYRAZOLO[1,5A]PYRIMIDIN-7-YL AMINE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISORDERS Novartis AG (CH) 2008-11-26 EP disclosed
WO-2007103432-A9 USE OF PYRAZOLO[1,5A]PYRIMIDIN-7-YL AMINE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISORDERS NOVARTIS AG (CH) 2008-01-10 WO disclosed
WO-2007103432-A2 USE OF PYRAZOLO[1,5A]PYRIMIDIN-7-YL AMINE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISORDERS NOVARTIS AG (CH) 2007-09-13 WO disclosed